325 related articles for article (PubMed ID: 25444433)
1. Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learned.
Iodice F; Testa G; Averardi M; Brancaccio G; Amodeo A; Cogo P
Neuromuscul Disord; 2015 Jan; 25(1):19-23. PubMed ID: 25444433
[TBL] [Abstract][Full Text] [Related]
2. Implantation of the HeartMate II and HeartWare left ventricular assist devices in patients with duchenne muscular dystrophy: lessons learned from the first applications.
Ryan TD; Jefferies JL; Sawnani H; Wong BL; Gardner A; Del Corral M; Lorts A; Morales DL
ASAIO J; 2014; 60(2):246-8. PubMed ID: 24577373
[TBL] [Abstract][Full Text] [Related]
3. Early extubation after left ventricular assist device implantation in a patient with Duchenne muscular dystrophy: a case report.
Kim HJ; Kim SY; Ju MH; Lee SY; Byeon GJ; Kim HY
J Anesth; 2021 Jun; 35(3):455-458. PubMed ID: 33782774
[TBL] [Abstract][Full Text] [Related]
4. Is there a future for the use of left ventricular assist devices in Duchenne muscular dystrophy?
Hayes EA; Nandi D
Pediatr Pulmonol; 2021 Apr; 56(4):753-759. PubMed ID: 33245216
[TBL] [Abstract][Full Text] [Related]
5. Is heart transplantation a real option in patients with Duchenne syndrome? Inferences from a case report.
Piperata A; Bottio T; Toscano G; Avesani M; Vianello A; Gerosa G
ESC Heart Fail; 2020 Oct; 7(5):3198-3202. PubMed ID: 32738034
[TBL] [Abstract][Full Text] [Related]
6. Obesity and Premature Loss of Mobility in Two Adolescents with Becker Muscular Dystrophy After HeartMate II Implantation.
Hollander SA; Rizzuto S; Hollander AM; Lin A; Liu E; Murray JM; Almond CS; Rosenthal DN
ASAIO J; 2016; 62(1):e5-7. PubMed ID: 26461240
[TBL] [Abstract][Full Text] [Related]
7. Use of trifurcate arch graft in left ventricular assist device implantation via the sternal sparing approach.
Mohite PN; Garcia-Saez D; Popov AF; Simon AR
J Thorac Cardiovasc Surg; 2015 Jun; 149(6):e113-4. PubMed ID: 25769773
[No Abstract] [Full Text] [Related]
8. Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results.
Perri G; Filippelli S; Adorisio R; Iacobelli R; Iodice F; Testa G; Paglietti MG; D'Amario D; Massetti M; Amodeo A
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):669-674. PubMed ID: 27692952
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular assist device in Duchenne cardiomyopathy: can we change the natural history of cardiac disease?
Amodeo A; Adorisio R
Int J Cardiol; 2012 Nov; 161(3):e43. PubMed ID: 22525347
[No Abstract] [Full Text] [Related]
10. Left Ventricular Tonic Contraction as a Novel Biomarker of Cardiomyopathy in Duchenne Muscular Dystrophy.
Su JA; Ramos-Platt L; Menteer J
Pediatr Cardiol; 2016 Apr; 37(4):678-85. PubMed ID: 26714815
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy.
Magnetta DA; Kang J; Wearden PD; Smith KJ; Feingold B
Pediatr Cardiol; 2018 Aug; 39(6):1242-1248. PubMed ID: 29774392
[TBL] [Abstract][Full Text] [Related]
12. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
[TBL] [Abstract][Full Text] [Related]
13. Rapidly Progressive Heart Failure in a Female Carrier of Becker Muscular Dystrophy with No Skeletal Muscle Symptoms.
Komoriyama H; Fukushima A; Takahashi Y; Kinugawa S; Sera F; Ohtani T; Nakamura A; Sakata Y; Anzai T
Intern Med; 2019 Sep; 58(17):2545-2549. PubMed ID: 31118394
[TBL] [Abstract][Full Text] [Related]
14. Under-recognition of Low Blood Pressure Readings in Patients with Duchenne Muscular Dystrophy.
Masood SA; Kazmouz S; Heydemann P; Li H; Kenny D
Pediatr Cardiol; 2015 Oct; 36(7):1489-94. PubMed ID: 25981564
[TBL] [Abstract][Full Text] [Related]
15. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
[TBL] [Abstract][Full Text] [Related]
16. [Management of myocardial damage in muscular dystrophy].
Tamura T
Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.
Connuck DM; Sleeper LA; Colan SD; Cox GF; Towbin JA; Lowe AM; Wilkinson JD; Orav EJ; Cuniberti L; Salbert BA; Lipshultz SE;
Am Heart J; 2008 Jun; 155(6):998-1005. PubMed ID: 18513510
[TBL] [Abstract][Full Text] [Related]
18. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure.
Esmore DS; Kaye D; Salamonsen R; Buckland M; Rowland M; Negri J; Rowley Y; Woodard J; Begg JR; Ayre P; Rosenfeldt FL
J Heart Lung Transplant; 2005 Aug; 24(8):1150-4. PubMed ID: 16102463
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Management of the Patient With Duchenne Muscular Dystrophy.
Buddhe S; Cripe L; Friedland-Little J; Kertesz N; Eghtesady P; Finder J; Hor K; Judge DP; Kinnett K; McNally EM; Raman S; Thompson WR; Wagner KR; Olson AK
Pediatrics; 2018 Oct; 142(Suppl 2):S72-S81. PubMed ID: 30275251
[TBL] [Abstract][Full Text] [Related]
20. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
